References
- BoppanaSHuangHItoKDhib-JalbutSImmunologic aspects of multiple sclerosisMt Sinai J Med201178220722021425265
- PolmanCHReingoldSCBanwellBDiagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteriaAnn Neurol201169229230221387374
- VollmerTThe natural history of relapses in multiple sclerosisJ Neurol Sci2007256Suppl 1S5S1317346747
- LublinFDBaierMCutterGEffect of relapses on development of residual deficit in multiple sclerosisNeurology200361111528153214663037
- National Clinical Advisory Board (National Multiple Sclerosis Society)Recommendations Regarding Corticosteroids in the Management of Multiple SclerosisNew York, NYNational Multiple Sclerosis Society2008
- HP Acthar® Gel (repository corticotropin) injection [prescribing information]Hayward, CAQuestcor Pharmaceuticals, Inc2012
- ArnasonBGBerkovichRCataniaALisakRPZaidiMMechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosisMult Scler201319213013623034287
- MillerHNewellDJRidleyAMultiple sclerosis. Treatment of acute exacerbations with corticotrophin (ACTH)Lancet196127872121120112214474011
- RoseASKuzmaJWKurtzkeJFNamerowNSSibleyWATourtellotteWWCooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs placebo – final reportNeurology19702051594314823
- ThompsonAJKennardCSwashMRelative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MSNeurology19893979699712544829
- FilippiniGBrusaferriFSibleyWACorticosteroids or ACTH for acute exacerbations in multiple sclerosisCochrane Database Syst Rev2000CD00133111034713
- SimsarianJPSaundersCSmithDMFive-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trialDrug Des Devel Ther20115381389
- SibleyWASpotlight series: pivotal trials through today’s knowledge – adrenocorticotrophic hormoneInt MS J2009162424619671367
- StafstromCEArnasonBGBaramTZTreatment of infantile spasms: emerging insights from clinical and basic science perspectivesJ Child Neurol201126111411142121719797
- BaramTZMitchellWGTournayASneadOCHansonRAHortonEJHigh-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded studyPediatrics19969733753798604274
- MackayMTWeissSKAdams-WebberTAmerican Academy of NeurologyChild Neurology SocietyPractice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology SocietyNeurology200462101668168115159460
- GoCYMackayMTWeissSKChild Neurology SocietyAmerican Academy of NeurologyEvidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology SocietyNeurology201278241974198022689735
- RossAPBen-ZachariaAHarrisCSmrtkaJMultiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormoneFront Neurol201342111223355832
- CataniaAGattiSColomboGLiptonJMTargeting melanocortin receptors as a novel strategy to control inflammationPharmacol Rev200456112915001661
- LugerTABrzoskaTalpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugsAnn Rheum Dis200766Suppl 3iii52iii5517934097
- BrzoskaTLugerTAMaaserCAbelsCBöhmMAlpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseasesEndocr Rev200829558160218612139
- BerkovichRTreatment of acute relapses in multiple sclerosisNeurotherapeutics20131019710523229226